Stock picks from our team of market veterans.
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
For the week ending Friday, February 13, 2026, FNArena tracked 31 upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.
While Artificial Intelligence fears may drive software-as-a-service stocks below their real worth, index investing can still play a role.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains in more detail why he believes that ORI is just undergoing a healthy consolidation and is ready to move higher again.
Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
For the week ending Friday 6th February 2026, FNArena tracked 23 upgrades and 14 downgrades for ASX-listed companies from brokers monitored daily.
Today I’m standing on the shoulders of great business builders to argue that this tech sell off is a buying opportunity. Stay with me on this!
In this article, we look at how our model portfolios have performed so far in 2026.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.